Software & Developer Tools
Abiologics
Abiologics is a Software & Developer Tools startup, most recent round Series A, 1 tracked investor.
activeseries-a
series-a
Stage
1
Investors
About Abiologics
Abiologics is a startup. Its most recent tracked round is Series A. Brouky classifies it under Software & Developer Tools. Brouky records 1 investor associated with the company.
Abiologics leverages artificial intelligence and chemical protein synthesis to create a new class of supranatural and programmable biologics called Synteins™, aimed at revolutionizing therapeutics across oncology, immunology, and metabolic diseases.
Explore Abiologics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.